Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models

Journal of Alzheimer's Disease

Volumn 6, Issue 4, 2004, Pages 367-377

  Baum, Larry ^a   Ng, Alex ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AD; Alzheimer's disease; Chelation; Chelator; Copper; Curcumin; Desferrioxamine; Iron; Metal; Zinc

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PROTEIN; CHELATING AGENT; CLIOQUINOL; COPPER; CURCUMIN; DEFEROXAMINE; DIKETONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; METAL CHELATE; POLYPHENOL DERIVATIVE; ZINC;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CHELATION; COGNITIVE DEFECT; CURCUMA LONGA; DISEASE MODEL; METABOLITE; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INDUCTION; SPECTROMETRY;

EID: 4644275696     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6403     Document Type: Article

References (64)

1. H. Ahsan, N. Parveen and N. Khan et al., Pro-oxidant, antioxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin, Chemico-Biol Interact 121 (1999), 161-175.
2. W.K. Alderton, C.E. Cooper and R.G. Knowles, Nitric oxide synthases: structure, function and inhibition, Biochem J 357 (2001), 593-615.
3. C.A.C. Araújo and L.L. Leon, Biological Activities of Curcuma longa L., Mem Inst Oswaldo Cruz, Rio de Janeiro 96 (2001), 723-728.
4. A. Asai and T. Miyazawa, Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma, Life Sci 67 (2000), 2785-2793.
5. C.S. Atwood, R.D. Moir and X. Huang et al., Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis, J Biol Chem 273 (1998), 12817-12826.
6. C.S. Atwood, R.C. Scarpa and X. Huang et al., Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar-Affinity Copper Binding Site on Amyloid β1-42, J Neurochem 75 (2000), 1219-1233.
7. H. Basun, L.G. Forssell and L. Wetterberg et al., Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease, J Neural Transm Park Dis Dement Sect 3 (1991), 231-258.
8. A. Becaria, S.C. Bondy and A. Campbell, Aluminum and copper interact in the promotion of oxidative but not inflammatory events: Implications for Alzheimer's disease, J Alz Dis 5 (2003), 31-38.
9. G. Began, E. Sudharshan and A.G. Appu Rao, Inhibition of lipoxygenase 1 by phosphatidylcholine micelles-bound curcumin, Lipids 33 (1998), 1223-1228.
10. G. Began, E. Sudharshan and K.U. Sankar et al., Interaction of Curcumin with Phosphatidylcholine: A Spectrofluorometric Study, J Agric Food Chem 47 (1999), 4992-4997.
11. F. Boato, G.M. Wortley, R.H. Liu and R.P. Glahn, Red grape juice inhibits iron availability: application of an in vitro digestion/caco-2 cell model, J Agric Food Chem 50 (2002), 6935-6938.
12. P. Brennan and L.A.J. O'Neill, Inhibition of Nuclear Factor κB by Direct Modification in Whole Cells - Mechanism of Action of Nordihydroguaiaritic Acid, Curcumin and Thiol Modifiers, Biochemical Pharmacology 55 (1998), 965-973.
13. V. Chandra, M. Ganguli and R. Pandav et al., Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US Study, Neurology 51 (1998), 1000-1008.
14. X. Chen, T. Hasuma and Y. Yano et al., Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin, Anticancer Res 17 (1997), 2555-2564.
15. R.A. Cherny, C.S. Atwood and M.E. Xilinas et al., Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice, Neuron 30 (2001), 665-676.
16. R.A. Cherny, J.T. Legg and C.A. McLean et al., Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal Depletion, J Biol Chem 274 (1999), 23223-23228.
17. D.R. Crapper McLachlan, A.J. Dalton and T.P. Kruck et al., Intramuscular desferrioxamine in patients with Alzheimer's disease, Lancet 337 (1991), 1304-1308.
18. M.P. Cuajungco, L.E. Goldstein and A. Nunomura et al., Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc, J Biol Chem 275 (2000), 19439-19442.
19. J.L. Cummings and G. Cole, Alzheimer disease, JAMA 287 (2002), 2335-2338.
20. M.R. D'Andrea, R.G. Nagele and H.Y. Wang et al., Consistent immunohistochemical detection of intracellular β-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex, Neurosci Lett 333 (2002), 163-166.
21. J.L. Dyer, S.Z. Khan and J.G. Bilmen et al., Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor, Cell Calcium 31 (2002), 45-52.
22. T. Dyrks, E. Dyrks and T. Hartmann et al., Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation, J Biol Chem 267 (1992), 18210-18217.
23. E.A. Eaton, U.K. Walle and A.J. Lewis et al., Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention, Drug Metab Dispos 24 (1996), 232-237.
24. V. Echeverria and A.C. Cuello, Intracellular A-beta amyloid, a sign for worse things to come? Mol Neurobiol 26 (2002), 299-316.
25. S.A. Frautschy et al., Unpublished data, Society for Neuroscience Meeting (2002).
26. S.A. Frautschy, W. Hu and P. Kim et al., Phenolic antiinflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology, Neurobiol Aging 22 (2001), 993-1005.
27. C. Gonzáles, T. Martin and J.B. Cacho et al., Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers, Eur J Clin Invest 29 (1999), 637-642.
28. D. Hamai, S.C. Bondy and A. Becaria et al., The chemistry of transition metals in relation to their potential role in neurodegenerative processes, Curr Top Med Chem 1 (2001), 541-551.
29. D.E. Hartter and A. Barnea, Evidence for release of copper in the brain: depolarization-induced release of newly taken-up 67copper, Synapse 2 (1988), 412-415.
30. X. Huang, C.S. Atwood and R.D. Moir et al., Zinc-induced Alzheimer's Aβ1-40 Aggregation Is Mediated by Conformational Factors, J Biol Chem 272 (1997), 26464-26470.
31. X. Huang, M.P. Cuajungco and C.S. Atwood et al., Alzheimer's disease, beta-amyloid protein and zinc, J Nutr 130 (2000), 1488S-1492S.
32. C. Ireson, S. Orr and D.J.L. Jones et al., Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rat Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production, Cancer Res 61 (2001), 1058-1064.
33. C. Jobin, C.A. Bradham and M.P. Russo et al., Curcumin Blocks Cytokine-Mediated NF-κB Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-κB Kinase Activity, The Journal of Immunology 163 (1999), 3474-3483.
34. I. Kasvosve, J.R. Delanghe and Z.A.R. Gomo et al., Transferrin Polymorphism Influences Iron Status in Blacks, Clin Chem 46 (2000), 1535-1539.
35. D.J. Lamb and D.S. Leake, Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein, FEBS Lett 338 (1994), 122-126.
36. G.P. Lim, T. Chu and F. Yang et al., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse, J Neurosci 21 (2001), 8370-8377.
37. J.K. Lin and S.Y. Lin-Shiau, Mechanisms of Cancer Chemoprevention by Curcumin, Proc Natl Sci Counc ROC(B) 25 (2001), 59-66.
38. J.K. Lin, M.H. Pan and S.Y. Lin-Shiau, Recent studies on the biofunctions and biotransformations of curcumin, Biofactors 13 (2000), 153-158.
39. D.A. Loeffler, A.J. DeMaggio and P.L. Juneau et al., Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease, Alzheimer Dis Assoc Disord 8 (1994), 190-197.
40. M.A. Lovell, J.D. Robertson and W.J. Teesdale et al., Copper, iron and zinc in Alzheimer's disease senile plaques, J Neurol Sci 158 (1998), 47-52.
41. M.A. Lovell, C. Xie and W.R. Markesbery, Protection against amyloid beta peptide toxicity by zinc, Brain Res 823 (1999), 88-95.
42. S. Moalem, M.E. Percy and D.F. Andrews et al., Are Hereditary Hemochromatosis Mutations Involved in Alzheimer Disease? Amer J Med Genet 93 (2000), 58-66.
43. R.D. Moir, C.S. Atwood and D.M. Romano et al., Differential Effects of Apolipoprotein E Isoforms on Metal-Induced Aggregation of Aβ Using Physiological Concentrations, Biochemistry 38 (1999), 4595-4603.
44. S. Oetari, M. Sudibyo and J.N.M. Commandeur et al., Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver, Biochem Pharmacol 51 (1996), 39-45.
45. K. Okada, C. Wangpoengtrakul and T. Tanaka et al., Curcumin and Especially Tetrahydrocurcumin Ameliorate Oxidative Stress-Induced Renal Injury in Mice, J Nutr 131 (2001), 2090-2095.
46. M.H. Pan, T.M. Huang and J.K. Lin, Biotransformation of curcumin through reduction and glucuronidation in mice, Drug Metab and Disposition 27 (1999), 486-494.
47. B.S. Patro, S. Rele and G.J. Chintalwar et al., Protective Activities of Some Phenolic 1,3-Diketones against Lipid Peroxidation: Possible Involvement of the 1,3-Diketone Moiety, ChemBioChem 3 (2002), 364-370.
48. J.L. Quiles, M.D. Mesa and C.L. Ramírez-Tortosa et al., Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits, Arterioscler Thromb Vasc Biol 22 (2002), 1225-1231.
49. C.A. Rottkamp, A.K. Raina and X. Zhu et al., Redox-active iron mediates amyloid-beta toxicity, Free Radic Biol Med 30 (2001), 447-450.
50. M. Sampietro, L. Caputo and A. Casatta et al., The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease, Neurobiol Aging 22 (2001), 563-568.
51. D.L. Samudralwar, C.C. Diprete and B.F. Ni et al., Elemental imbalances in the olfactory pathway in Alzheimer's disease, J Neurol Sci 130 (1995), 139-145.
52. M. Sano, C. Ernesto and R.G. Thomas et al., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N Engl J Med 336 (1997), 1216-1222.
53. P.H. Sato and V.G. Zannoni, Ascorbic acid and hepatic drug metabolism, J Pharmacol Exp Ther 198 (1976), 295-307.
54. 2+ ion with milk xanthine oxidase, Biochimica et Biophysica Acta 1544 (2001), 89-95.
55. E. Skrzypczak-Jankun, N.P. McCabe, S.H. Selman and J. Jankun, Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence, Int J Mol Med 6 (2000), 521-526.
56. D.L. Sparks, Intraneuronal beta-amyloid immunoreactivity in the CNS, Neurobiol Aging 17 (1996), 291-299.
57. Sreejayan and M.N.A. Rao, Curcuminoids as Potent Inhibitors of Lipid Peroxidation, J Pharm Pharmacol 46 (1994), 1013-1016.
58. Y.J. Wang, M.H. Pan and A.L. Cheng et al., Stability of curcumin in buffer solutions and characterization of its degradation products, J Pharm Biomed Anal 15 (1997), 1867-1876.
59. S. Xiong, H. She and H. Takeuchi et al., Signaling Role of Intracellular Iron in NF-κB Activation, J Biol Chem 278 (2003), 17646-17654.
60. H. Yamamoto, K. Hanada and K. Kawasaki et al., Inhibitory effect of curcumin on mammalian phospholipase D activity, FEBS Lett 417 (1997), 196-198.
61. J.J. Yan, J.Y. Cho and H.S. Kim et al., Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid, British J Pharmacol 133 (2001), 89-96.
62. F. Yang, T. Morihara and W. Beech et al., Curcumin stimulates microglia phagocytosis of amyloid in vivo and in vitro, Abstract Viewer/Itinerary Planner CD-ROM, Washington, DC: Society for Neuroscience (2002), Program No. 192.3.
63. Y. Yoshiike, K. Tanemura and O. Murayama et al., New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity, J Biol Chem 276 (2001), 32293-32299.
64. K. Zou, J.S. Gong and K. Yanagisawa et al., A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage, J Neurosci 22 (2002), 4833-4841.